Multi-specific human albumin nanoparticles decorated with antibody fragments and loaded with cytotoxics
AssigneeAnbition S.R.L.
InventorsMenotti Ruvo, Sandro De Falco, Davide Rosiello
Life of this patent
Estimating the term…
Loading patent…
AssigneeAnbition S.R.L.
InventorsMenotti Ruvo, Sandro De Falco, Davide Rosiello
Estimating the term…
The invention relates to serum albumin nanoparticles, preferably human, optionally loaded with a cytotoxic drug, decorated on the surface with at least one biological molecule capable of recognising over-expressed or selectively expressed target receptors on the surface of cells, preferably cancer cells. In particular, the serum albumin nanoparticles (Alb-NP) are decorated with at least one decoration chain comprising: ⋅ a linker, bound to the nanoparticles by means of an —S— thioether bond, and ⋅ at least one biological molecule. The at least one biological molecule is bound to the linker through an amide bond formed by means of a transamidation (or transglutamination) reaction, mediated by the enzyme transglutaminase, between: (I) the —NH2 residue of an X group of a linker and the —CO—NH2 residue of a glutamine comprised in a peptide consensus sequence inserted in the at least one biological molecule; or (ii) the —NH2 residue of a lysine comprised in a peptide sequence inserted in the at least one biological molecule and the —CO—NH2 residue of a glutamine inserted in a consensus sequence which is part of the linker.
Serum albumin nanoparticles (Alb-NP) decorated with at least one decoration chain comprising:
Dependencies are inferred from the claim text.